A long-term survivor keeping in a complete response without treatment after pemetrexed maintenance therapy for advanced non-squamous non-small cell lung cancer

被引：0

作者：

Furugen, Makoto ^{[1
]}

Shibahara, Daisuke ^{[1
]}

Kiyuna, Tomo ^{[1
]}

Kami, Wakaki ^{[1
]}

Miyagi, Kazuya ^{[1
]}

Haranaga, Shusaku ^{[1
]}

Kubota, Toru ^{[2
]}

Matsumoto, Hirofumi ^{[3
]}

Yoshimi, Naoki ^{[4
]}

Fujita, Jiro ^{[1
]}

机构：

[1] Univ Ryukyus, Grad Sch Med, Dept Infect Resp & Digest Med, 207 Uehara, Nishihara, Okinawa 9030215, Japan

[2] Omoromachi Med Ctr Hosp, Okinawa, Japan

[3] Nakagami Hosp, Dept Pathol Diag, Okinawa, Japan

[4] Okinawa Red Cross Hosp, Dept Pathol Diag, Okinawa, Japan

来源：

CLINICAL CASE REPORTS | 2021年 / 9卷 / 02期

关键词：

complete response; cytotoxic drug; long-term survivor; non-squamous non-small cell lung cancer; pemetrexed maintenance therapy; PHASE-III; THYMIDYLATE SYNTHASE; INDUCTION TREATMENT; PLUS CISPLATIN; CHEMOTHERAPY;

D O I：

10.1002/ccr3.3650

中图分类号：

R5 [内科学];

学科分类号：

1002 ; 100201 ;

摘要：

Pemetrexed has significant efficacy for some non-squamous non-small cell lung cancer cases, as demonstrated in the current case. For those patients, pemetrexed administration should be carefully considered.

引用

页码：927 / 931

页数：5

共 15 条

[1] Thymidylate synthase and dihydrofolate reductase expression in non-small cell lung carcinoma: The association with treatment efficacy of pemetrexed [J].

Chen, Chung-Yu ;

Chang, Yih-Leong ;

Shih, Jin-Yuan ;

Lin, Jou-Wei ;

Chen, Kuan-Yu ;

Yang, Chih-Hsin ;

Yu, Chong-Jen ;

Yang, Pan-Chyr .

LUNG CANCER, 2011, 74 (01) :132-138

[2] Guidelines for Pathologic Diagnosis of Malignant Mesothelioma 2017 Update of the Consensus Statement From the International Mesothelioma Interest Group [J].

Husain, Aliya Noor ;

Colby, Thomas V. ;

Ordonez, Nelson G. ;

Allen, Timothy Craig ;

Attanoos, Richard Luther ;

Beasley, Mary Beth ;

Butnor, Kelly Jo ;

Chirieac, Lucian R. ;

Churg, Andrew M. ;

Dacic, Sanja ;

Galateau-Salle, Francoise ;

Gibbs, Allen ;

Gown, Allen M. ;

Krausz, Thomas ;

Litzky, Leslie Anne ;

Marchevsky, Alberto ;

Nicholson, Andrew G. ;

Roggli, Victor Louis ;

Sharma, Anupama K. ;

Travis, William D. ;

Walts, Ann E. ;

Wick, Mark R. .

ARCHIVES OF PATHOLOGY & LABORATORY MEDICINE, 2018, 142 (01) :89-108

[3] Real world treatment and outcomes in EGFR mutation-positive non-small cell lung cancer: Long-term follow-up of a large patient cohort [J].

Okamoto, Isamu ;

Morita, Satoshi ;

Tashiro, Naoki ;

Imamura, Fumio ;

Inoue, Akira ;

Seto, Takashi ;

Yamamoto, Nobuyuki ;

Ohe, Yuichiro ;

Nakagawa, Kazuhiko ;

Fukuoka, Masahiro .

LUNG CANCER, 2018, 117 :14-19

[4] Significance of thymidylate synthase for resistance to pemetrexed in lung cancer [J].

Ozasa, Hiroaki ;

Oguri, Tetsuya ;

Uemura, Takehiro ;

Miyazaki, Mikinori ;

Maeno, Ken ;

Sato, Shigeki ;

Ueda, Ryuzo .

CANCER SCIENCE, 2010, 101 (01) :161-166

[5] PARAMOUNT: Final Overall Survival Results of the Phase III Study of Maintenance Pemetrexed Versus Placebo Immediately After Induction Treatment With Pemetrexed Plus Cisplatin for Advanced Nonsquamous Non-Small-Cell Lung Cancer [J].

Paz-Ares, Luis G. ;

de Marinis, Filippo ;

Dediu, Mircea ;

Thomas, Michael ;

Pujol, Jean-Louis ;

Bidoli, Paolo ;

Molinier, Olivier ;

Sahoo, Tarini Prasad ;

Laack, Eckart ;

Reck, Martin ;

Corral, Jesus ;

Melemed, Symantha ;

John, William ;

Chouaki, Nadia ;

Zimmermann, Annamaria H. ;

Visseren-Grul, Carla ;

Gridelli, Cesare .

JOURNAL OF CLINICAL ONCOLOGY, 2013, 31 (23) :2895-+

[6] Long-Term and Low-Grade Safety Results of a Phase III Study (PARAMOUNT): Maintenance Pemetrexed Plus Best Supportive Care Versus Placebo Plus Best Supportive Care Immediately After Induction Treatment With Pemetrexed Plus Cisplatin for Advanced Nonsquamous Non-Small-Cell Lung Cancer [J].

Pujol, Jean-Louis ;

Paz-Ares, Luis ;

de Marinis, Filippo ;

Dediu, Mircea ;

Thomas, Michael ;

Bidoli, Paolo ;

Corral, Jesus ;

San Antonio, Belen ;

Chouaki, Nadia ;

John, William ;

Zimmermann, Annamaria ;

Visseren-Grul, Carla ;

Gridelli, Cesare .

CLINICAL LUNG CANCER, 2014, 15 (06) :418-425

[7] Pembrolizumab versus Chemotherapy for PD-L1-Positive Non-Small-Cell Lung Cancer [J].

Reck, Martin ;

Rodriguez-Abreu, Delvys ;

Robinson, Andrew G. ;

Hui, Rina ;

Csoszi, Tibor ;

Fulop, Andrea ;

Gottfried, Maya ;

Peled, Nir ;

Tafreshi, Ali ;

Cuffe, Sinead ;

O'Brien, Mary ;

Rao, Suman ;

Hotta, Katsuyuki ;

Leiby, Melanie A. ;

Lubiniecki, Gregory M. ;

Shentu, Yue ;

Rangwala, Reshma ;

Brahmer, Julie R. .

NEW ENGLAND JOURNAL OF MEDICINE, 2016, 375 (19) :1823-1833

[8] Chemotherapy curable malignancies and cancer stem cells: a biological review and hypothesis [J].

Savage, Philip .

BMC CANCER, 2016, 16

[9] The Differential Efficacy of Pemetrexed According to NSCLC Histology: A Review of Two Phase III Studies [J].

Scagliotti, Giorgio ;

Hanna, Nasser ;

Fossella, Frank ;

Sugarman, Katherine ;

Blatter, Johannes ;

Peterson, Patrick ;

Simms, Lorinda ;

Shepherd, Frances A. .

ONCOLOGIST, 2009, 14 (03) :253-263

[10] Phase III study comparing cisplatin plus gemcitabine with cisplatin plus pemetrexed in chemotherapy-naive patients with advanced-stage non-small-cell lung cancer [J].

Scagliotti, Giorgio Vittorio ;

Parikh, Purvish ;

von Pawel, Joachim ;

Biesma, Bonne ;

Vansteenkiste, Johan ;

Manegold, Christian ;

Serwatowski, Piotr ;

Gatzemeier, Ulrich ;

Digumarti, Raghunadharao ;

Zukin, Mauro ;

Lee, Jin S. ;

Mellemgaard, Anders ;

Park, Keunchil ;

Patil, Shehkar ;

Rolski, Janusz ;

Goksel, Tuncay ;

de Marinis, Filippo ;

Simms, Lorinda ;

Sugarman, Katherine P. ;

Gandara, David .

JOURNAL OF CLINICAL ONCOLOGY, 2008, 26 (21) :3543-3551

← 1 2 →